Retham Technologies™ LLC was established in 2017 to translate discoveries from the BloodCenter of Wisconsin into life-saving in vitro diagnostic (IVD) assays that provide earlier and more accurate in-hospital diagnosis of Heparin-induced Thrombocytopenia (HIT).